194 related articles for article (PubMed ID: 30884325)
1. Electrochemical simulation of metabolism for antitumor-active imidazoacridinone C-1311 and in silico prediction of drug metabolic reactions.
Potęga A; Żelaszczyk D; Mazerska Z
J Pharm Biomed Anal; 2019 May; 169():269-278. PubMed ID: 30884325
[TBL] [Abstract][Full Text] [Related]
2. Electrochemical generation of selegiline metabolites coupled to mass spectrometry.
Mielczarek P; Smoluch M; Kotlinska JH; Labuz K; Gotszalk T; Babij M; Suder P; Silberring J
J Chromatogr A; 2015 Apr; 1389():96-103. PubMed ID: 25746755
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the biotransformation pathway of verapamil using electrochemistry/liquid chromatography/mass spectrometry - a comparative study with liver cell microsomes.
Jahn S; Baumann A; Roscher J; Hense K; Zazzeroni R; Karst U
J Chromatogr A; 2011 Dec; 1218(51):9210-20. PubMed ID: 22098935
[TBL] [Abstract][Full Text] [Related]
4. Phase I and phase II metabolism simulation of antitumor-active 2-hydroxyacridinone with electrochemistry coupled on-line with mass spectrometry.
Potęga A; Garwolińska D; Nowicka AM; Fau M; Kot-Wasik A; Mazerska Z
Xenobiotica; 2019 Aug; 49(8):922-934. PubMed ID: 30301406
[TBL] [Abstract][Full Text] [Related]
5. Prediction of biotransformation products of the fungicide fluopyram by electrochemistry coupled online to liquid chromatography-mass spectrometry and comparison with in vitro microsomal assays.
Mekonnen TF; Panne U; Koch M
Anal Bioanal Chem; 2018 Apr; 410(10):2607-2617. PubMed ID: 29455286
[TBL] [Abstract][Full Text] [Related]
6. Oxidative metabolism of typical phenolic compounds of Danshen by electrochemistry coupled to quadrupole time-of-flight tandem mass spectrometry.
Yang J; Chen Y; Zhen XT; Dong X; Ye LH; Zheng H; Cao J
Food Chem; 2020 Jun; 315():126270. PubMed ID: 32028199
[TBL] [Abstract][Full Text] [Related]
7. Electrochemical and
Potęga A; Żelaszczyk D; Mazerska Z
J Pharm Anal; 2020 Aug; 10(4):376-384. PubMed ID: 32923012
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of electrochemically and in vivo generated potential metabolites of selected cardiovascular drugs by EC-UHPLC/ESI-MS using an experimental design approach.
Szultka-Młyńska M; Bajkacz S; Baranowska I; Buszewski B
Talanta; 2018 Jan; 176():262-276. PubMed ID: 28917751
[TBL] [Abstract][Full Text] [Related]
9. Electrochemistry/mass spectrometry (EC/MS) for fast generation and identification of novel reactive metabolites of two unsymmetrical bisacridines with anticancer activity.
Potęga A; Göldner V; Niehaves E; Paluszkiewicz E; Karst U
J Pharm Biomed Anal; 2023 Oct; 235():115607. PubMed ID: 37523868
[TBL] [Abstract][Full Text] [Related]
10. Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry/separations/mass spectrometry.
Telgmann L; Faber H; Jahn S; Melles D; Simon H; Sperling M; Karst U
J Chromatogr A; 2012 Jun; 1240():147-55. PubMed ID: 22525874
[TBL] [Abstract][Full Text] [Related]
11. Electrochemical oxidation of selected immunosuppressants and identification of their oxidation products by means of liquid chromatography and tandem mass spectrometry (EC-HPLC-MS/MS).
Szultka-Mlynska M; Buszewski B
J Pharm Biomed Anal; 2019 Nov; 176():112799. PubMed ID: 31394306
[TBL] [Abstract][Full Text] [Related]
12. P450-catalyzed vs. electrochemical oxidation of haloperidol studied by ultra-performance liquid chromatography/electrospray ionization mass spectrometry.
Mali'n TJ; Weidolf L; Castagnoli N; Jurva U
Rapid Commun Mass Spectrom; 2010 May; 24(9):1231-40. PubMed ID: 20391593
[TBL] [Abstract][Full Text] [Related]
13. Electrochemical simulation of metabolic reduction and conjugation reactions of unsymmetrical bisacridine antitumor agents, C-2028 and C-2053.
Potęga A; Paczkowski S; Paluszkiewicz E; Mazerska Z
J Pharm Biomed Anal; 2021 Apr; 197():113970. PubMed ID: 33618132
[TBL] [Abstract][Full Text] [Related]
14. Electrochemistry-mass spectrometry for in-vitro determination of selected chemotherapeutics and their electrochemical products in comparison to in-vivo approach.
Szultka-Mlynska M; Buszewski B
Talanta; 2016 Nov; 160():694-703. PubMed ID: 27591665
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of the enzymatic oxidation investigated for imidazoacridinone antitumor drug, C-1311.
Mazerska Z; Sowiński P; Konopa J
Biochem Pharmacol; 2003 Nov; 66(9):1727-36. PubMed ID: 14563483
[TBL] [Abstract][Full Text] [Related]
16. Electrochemical simulation of three novel cardiovascular drugs phase I metabolism and development of a new method for determination of them by liquid chromatography coupled with tandem mass spectrometry.
Szultka-Młyńska M; Bajkacz S; Kaca M; Baranowska I; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():100-112. PubMed ID: 30015307
[TBL] [Abstract][Full Text] [Related]
17. Electrochemical simulation of biotransformation reactions of citrinin and dihydroergocristine compared to UV irradiation and Fenton-like reaction.
Keller J; Haase H; Koch M
Anal Bioanal Chem; 2017 Jun; 409(16):4037-4045. PubMed ID: 28424858
[TBL] [Abstract][Full Text] [Related]
18. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.
Baumann A; Karst U
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):715-31. PubMed ID: 20370599
[TBL] [Abstract][Full Text] [Related]
19. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
[TBL] [Abstract][Full Text] [Related]
20. Mimicry of phase I drug metabolism--novel methods for metabolite characterization and synthesis.
Johansson T; Weidolf L; Jurva U
Rapid Commun Mass Spectrom; 2007; 21(14):2323-31. PubMed ID: 17575570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
